Acquired Von Willebrand Syndrome (AVWS)

Acquired von Willebrand syndrome (AVWS) is a bleeding problem that starts later in life. It is not inherited from parents. It happens because another disease or a medical device changes the level or the quality of a blood protein called von Willebrand factor (VWF). VWF helps platelets stick to a wound and also carries factor VIII, another clotting protein. In AVWS, VWF becomes too low or does not work well, so bleeding lasts longer. The lab tests often look like the inherited form of von Willebrand disease (VWD), but there is no family history and the person usually did not bleed in childhood. Treating the underlying cause often improves the bleeding. HaematologicaGenetic Rare Diseases Center

Thrombotic thrombocytopenic purpura (TTP), acquired is a blood disorder characterized by low platelets (i.e., thrombocytopenia), small areas of bleeding under the skin (i.e., purpura), low red blood cell count, and hemolytic anemia. TTP causes blood clots (thrombi) to form in small blood vessels throughout the body. These clots can cause medical problems if they block vessels and decrease or stop blood flow to organs such as the brain, kidneys, and heart. Complications may include neurological problems (such as personality changes, headaches, confusion, and slurred speech), fever, abnormal kidney function, abdominal pain, and heart problems. Hemolytic anemia can lead to paleness, yellowing of the eyes and skin (jaundice), fatigue, shortness of breath, and a rapid heart rate. Acquired TTP usually begins in adulthood, but can affect children. An episode of TTP usually occurs suddenly and lasts for days or weeks, but it may continue for months. Relapses (or flareups) can occur in up to 60 percent of people who have the acquired TTP. Acquired TTP is caused when a person’s body mistakingly makes antibodies that block the activity of the ADAMTS13 enzyme. THe ADAMTS13 enzyme normally helps control the activity of certain blood clotting factors.

Acquired von Willebrand syndrome (AVWS) is a bleeding problem that starts later in life. You are not born with it. It happens because your body loses or damages a blood-clotting helper called von Willebrand factor (VWF). VWF normally helps platelets stick to injured blood vessels and also protects clotting factor VIII. In AVWS, something outside the gene lowers VWF or makes it work poorly. Typical triggers are other diseases (for example, some blood cancers, heart valve disease, very high platelet counts), immune reactions against VWF, or strong blood flow forces that break VWF into smaller, weaker pieces. People notice easy bruising, nosebleeds, gum bleeding, heavy periods, bleeding after dental work or surgery, or iron-loss anemia. The condition looks like inherited VWD in lab tests, but there is no childhood bleeding story and often no family history. Treating the underlying cause and using VWF-supporting treatments usually control bleeding. PMCPubMedFrontiers

Other names

People may also call this problem: “acquired von Willebrand disease,” “acquired deficiency of VWF,” or simply “acquired VWD.” When AVWS is linked to aortic valve narrowing with bowel bleeding from fragile vessels, the whole picture is often called Heyde syndrome. NCBI

Types

1. Autoantibody-mediated type.
   Sometimes the body makes antibodies that attach to VWF. This can block VWF function or speed up its removal from blood. The blood then loses the large, most useful VWF “multimers,” and bleeding increases. This happens in some immune or blood cancers. Haematologica

2. Adsorption type (sticking to cells).
   Abnormal cells (for example in some lymphomas, leukemias, or with very high platelets) can “soak up” VWF on their surface. Stuck VWF is cleared from the blood, so levels fall and bleeding risk rises. PMCHaematologica

3. Shear-stress type (mechanical loss).
   High blood flow stress through tight valves or pumps (like severe aortic stenosis or LVADs) unfolds VWF so it gets cut into small pieces. The largest multimers disappear, and bleeding—especially from the gut—can follow. Fixing the valve or device often improves it. PMCAsh Publications

4. Reduced production/secretion type.
   In hypothyroidism, the body makes and releases less VWF, so levels drop. Thyroid hormone replacement can correct this. PMC

5. Mixed/other type.
   Some drugs or rare tumors change VWF in more than one way (blocking, clearing, or breaking it down). The exact mechanism can be mixed. PubMed

Causes

1. Monoclonal gammopathy of undetermined significance (MGUS).
   An abnormal antibody made by plasma cells can bind VWF and clear it from blood, causing easy bleeding. ScienceDirect

2. Multiple myeloma.
   Many abnormal antibodies in myeloma can attach to VWF and lower its level or function. ScienceDirect

3. Waldenström macroglobulinemia.
   Very large IgM proteins increase blood thickness and can bind VWF, reducing helpful multimers. ScienceDirect

4. Non-Hodgkin lymphoma.
   Cancer cells may adsorb VWF or trigger antibodies to it, so bleeding starts or worsens. ScienceDirect

5. Chronic lymphocytic leukemia (CLL).
   CLL can lead to antibodies against VWF or increased clearance, making mucosal bleeding more likely. ScienceDirect

6. Essential thrombocythemia (ET).
   Very high platelet counts (>1,000 ×10⁹/L) can bind and remove large VWF multimers, so nose and gum bleeding occurs despite “too many” platelets. PMC

7. Polycythemia vera (PV).
   This myeloproliferative disease may also disturb VWF and raise bleeding risk, especially when platelets are very high. DynaMed

8. Primary myelofibrosis.
   Abnormal marrow cells and high platelets can lower effective VWF and cause bruising or nosebleeds. DynaMed

9. Severe aortic stenosis (Heyde syndrome).
   Tight aortic valves increase shear stress that chops VWF; patients bleed from gut angiodysplasia until the valve is fixed. PMC

10. Mechanical heart valves or valve prosthesis problems.
    Damaged or leaking prostheses increase shear forces and reduce large VWF multimers, leading to bleeding. JAMA Network

11. Left ventricular assist devices (LVADs).
    Continuous-flow pumps produce high shear that quickly removes large VWF multimers; GI bleeding is common. Ash Publications

12. Extracorporeal membrane oxygenation (ECMO).
    The circuit and pump cause shear-related VWF loss and bleeding in some patients. The Blood Project

13. Congenital heart lesions with high flow jets.
    Defects that create fast jets (e.g., some septal defects) may cut VWF and cause mucosal bleeding. WikiDoc

14. Hypothyroidism.
    Low thyroid hormone reduces VWF production/release, so levels fall; replacement therapy reverses it. PMC

15. Systemic lupus erythematosus (SLE).
    Autoimmune activity can form anti-VWF antibodies or speed clearance, lowering function. PubMed

16. Antiphospholipid antibody syndrome.
    Immune changes may alter VWF interaction with platelets and vessel walls, contributing to acquired deficiency. Genetic Rare Diseases Center

17. Solid tumors (various).
    Some cancers express surfaces that bind VWF or trigger antibodies to it, causing bleeding as a first sign. PubMed

18. Uremia (advanced kidney failure).
    Toxins in blood alter platelet-VWF interaction and may reduce effective VWF activity. WikiDoc

19. Certain drugs (rare).
    A few reports link agents like valproic acid or ciprofloxacin with acquired VWF problems that improve when the drug is stopped. These are uncommon and often temporary. WikiDoc

20. Unknown cause (idiopathic).
    In a small group, no clear trigger is found. The lab picture still shows AVWS, and doctors search carefully for hidden disease. PubMed

Symptoms

1. Easy bruising.
   Small bumps cause large bruises because blood does not clot quickly on the skin. NCBI

2. Frequent nosebleeds.
   Bleeding from the front of the nose starts easily and is hard to stop. MedlinePlus

3. Bleeding gums.
   Teeth brushing or dental work may cause long bleeding because VWF is low or weak. NCBI

4. Prolonged bleeding from cuts.
   Minor cuts ooze for a long time because platelets cannot stick well without good VWF. NCBI

5. Heavy menstrual bleeding (menorrhagia).
   Periods last longer, with clots or flooding, and can cause iron-deficiency anemia. StatPearls

6. Bleeding after surgery or dental care.
   Bleeding lasts longer than expected after procedures, even small ones. MedlinePlus

7. Gastrointestinal bleeding.
   Stool may be black or red; in aortic stenosis, fragile bowel vessels (angiodysplasia) often bleed again and again. PMC

8. Blood in urine (hematuria).
   Urine turns pink or red after minor strain or infection due to mucosal bleeding. NCBI

9. Petechiae.
   Tiny red dots on the skin show small capillary bleeds. NCBI

10. Purpura/ecchymoses.
    Larger purple patches form after mild trauma because clotting is slow. NCBI

11. Bleeding after childbirth.
    Some patients bleed more than expected postpartum due to poor VWF function. PubMed

12. Anemia symptoms.
    Tiredness, dizziness, or shortness of breath can come from chronic blood loss. NCBI

13. Prolonged oozing from IV or injection sites.
    Small punctures may ooze longer than usual. NCBI

14. Recurrent mouth sores bleeding.
    Minor bites or ulcers bleed longer. NCBI

15. No childhood bleeding history.
    People usually report normal childhood bleeding; symptoms begin later, when the trigger disease appears. Haematologica

Diagnostic tests

A) Physical exam

1. Skin and mucosa check.
   The doctor looks for petechiae, purpura, and gum bleeding. These signs suggest a mucocutaneous bleeding problem like AVWS. NCBI

2. Nose and mouth exam.
   Anterior rhinoscopy and oral inspection help find active bleeding points and assess how easily bleeding starts. NCBI

3. Gynecologic assessment.
   History and exam for heavy periods or postpartum bleeding point toward a VWF-related disorder. PubMed

4. Abdomen and rectal exam.
   Doctors check for enlarged spleen or liver and test stool color; melena suggests GI bleeding. NCBI

5. Cardiac auscultation.
   A harsh aortic murmur raises suspicion for Heyde syndrome, where AVWS comes from aortic stenosis. NCBI

B) Manual tests

6. ISTH Bleeding Assessment Tool (BAT).
   This is a simple scoring of lifetime bleeding symptoms. A high score supports a VWF-type disorder and guides lab testing. American Society of Hematology

7. Ivy bleeding time (historical).
   A small standardized cut is timed to stop bleeding. It is rarely used today because it is not reliable, but it explains the clinical picture to patients. PubMed

8. Tourniquet (Rumpel-Leede) test (rarely used).
   A blood pressure cuff briefly raises venous pressure; new petechiae suggest capillary fragility and platelet/VWF problems. It is a crude, old test. NCBI

9. Bedside fecal occult blood (guaiac) test.
   A simple card test checks stool for hidden blood when anemia or dark stools are present. NCBI

C) Laboratory & pathological tests

10. Complete blood count (CBC) and smear.
    This shows anemia from blood loss and platelet count. Very high platelets suggest ET-related AVWS. PMC

11. PT and aPTT.
    aPTT may be prolonged if factor VIII is low because VWF carries it. PT is usually normal. NCBI

12. VWF antigen (VWF:Ag).
    This measures how much VWF is in blood. It is often low in AVWS. PubMed

13. VWF activity (platelet GPIb binding; VWF:RCo or GPIbM).
    This measures how well VWF works. In AVWS the activity can be very low, often lower than the antigen. PubMed

14. Factor VIII activity (FVIII:C).
    This is often reduced because VWF stabilizes FVIII; low FVIII supports a VWF-related bleeding disorder. PubMed

15. VWF collagen-binding (VWF:CB) and activity/antigen ratios.
    Ratios like VWF:RCo/Ag or VWF:CB/Ag help show qualitative VWF defects and loss of large multimers typical of AVWS. PubMed

16. Anti-VWF antibody testing (ELISA/inhibitor screen).
    This looks for immune antibodies that neutralize or clear VWF in autoimmune and lymphoid disorders. Haematologica

D) “Electrodiagnostic” laboratory assays

17. VWF multimer analysis (gel electrophoresis).
    This specialized test separates VWF by size. Loss of high-molecular-weight (HMW) multimers is a hallmark in shear-stress and adsorption types of AVWS. PubMed

18. Serum protein electrophoresis with immunofixation.
    This detects monoclonal proteins from MGUS or myeloma that can bind and clear VWF. ScienceDirect

E) Imaging and endoscopic tests

19. Echocardiography (TTE/TEE).
    An ultrasound of the heart checks for aortic stenosis or prosthetic valve problems that create high shear and destroy VWF multimers. PMCJAMA Network

20. GI endoscopy or capsule endoscopy.
    These look for angiodysplasia and other bleeding sources in the gut, which are common in AVWS from valve disease or LVADs.

Non-pharmacological treatments

A) Physiotherapy & physical-care strategies

These are safe, daily actions that lower bleeding risk and protect joints and tissues.

1. Gentle aerobic exercise (walking, cycling, swimming).
   Purpose: maintain fitness without trauma. Mechanism: low-impact movement reduces falls and muscle tears. Benefit: fewer bleeds and better stamina.

2. Strength training with light resistance, slow tempo.
   Purpose: build muscle support. Mechanism: stronger muscles stabilize joints and vessels. Benefit: fewer strains and bruises.

3. Flexibility and range-of-motion work.
   Purpose: keep joints mobile. Mechanism: gentle stretching lowers micro-tears. Benefit: less post-exercise soreness and bleeding.

4. Balance training (heel-to-toe walk, single-leg stance near support).
   Purpose: prevent falls. Mechanism: better proprioception. Benefit: fewer injury-related bleeds.

5. Protective gear for risky tasks (gloves in kitchen/yard, shin guards for specific sports).
   Purpose: prevent cuts. Mechanism: physical barrier. Benefit: fewer skin/mucosal bleeds.

6. Dental hygiene routine (soft toothbrush, floss gently, fluoride).
   Purpose: avoid gum bleeding triggers like gingivitis. Mechanism: lowers local inflammation and friability. Benefit: fewer mouth bleeds.

7. Humidified air + saline nasal care.
   Purpose: prevent nosebleeds. Mechanism: keeps mucosa moist, less cracking. Benefit: fewer epistaxis events.

8. RICE for soft-tissue bleeds (rest, ice, compression, elevate).
   Purpose: limit bleed size. Mechanism: vasoconstriction and pressure slow ooze. Benefit: faster control and less pain/swelling.

9. Compression garments for minor muscle bleeds (as advised by clinician).
   Purpose: support and pressure. Mechanism: reduces tissue space for blood spread. Benefit: quicker recovery.

10. Safe-lifting techniques (hip hinge, avoid jerks).
    Purpose: prevent muscle tears. Mechanism: controlled motion. Benefit: less bruising.

11. Activity pacing and warm-up/cool-down.
    Purpose: reduce sudden strain. Mechanism: gradual tissue loading. Benefit: fewer acute injuries.

12. Physio-guided rehab after any bleed.
    Purpose: restore function safely. Mechanism: staged protocols. Benefit: avoids re-bleed and stiffness.

13. Skin care (emollients, careful shaving or electric razors).
    Purpose: reduce nicks. Mechanism: better skin barrier. Benefit: less superficial bleeding.

14. Ergonomic home adjustments (non-slip mats, good lighting, handrails).
    Purpose: prevent falls and cuts. Mechanism: hazard control. Benefit: safer daily living.

15. Advance planning for dental/medical procedures (tell providers early).
    Purpose: prevent peri-procedural bleeding. Mechanism: allows hemostatic plan (antifibrinolytics, VWF therapy). Benefit: safer procedures. Ash Publications

B) Mind-body, education, and “gene therapy” notes

16. Bleeding-risk education (you and your family).
    Purpose: know what triggers bleeds and what to do. Mechanism: knowledge → rapid response. Benefit: fewer emergencies.

17. Personal emergency plan and wallet card.
    Purpose: share diagnosis fast. Mechanism: info for clinicians in urgent care. Benefit: quicker, correct treatment.

18. Medication review & deprescribing of antiplatelet/herbal agents when safe.
    Purpose: remove bleed-worsening drugs. Mechanism: less platelet inhibition/anticoagulation. Benefit: fewer spontaneous bleeds. (Never stop a heart/stroke medicine without your prescriber.)

19. Stress-reduction tools (paced breathing, brief mindfulness).
    Purpose: steady blood pressure and reduce nose/mouth bleeds. Mechanism: lowers sympathetic surges. Benefit: fewer stress-linked bleeds.

20. Menstrual planning (track cycles; discuss options like LNG-IUD or tranexamic plan).
    Purpose: reduce heavy periods. Mechanism: hormonal/endometrial effects; antifibrinolysis. Benefit: better iron stores and energy.

21. Nutrition coaching (iron-rich food, vitamin C with iron, avoid alcohol excess).
    Purpose: keep hemoglobin up. Mechanism: supports red cell building; less mucosal fragility. Benefit: less fatigue.

22. Infection-prevention hygiene (handwashing, vaccines as advised).
    Purpose: avoid bleeds triggered by cough/nose blowing. Mechanism: fewer URIs. Benefit: fewer epistaxis episodes.

23. Home first-aid kit (gauze, nasal clamp, tranexamic prescriptions if given).
    Purpose: treat small bleeds early. Mechanism: compression + medications as prescribed. Benefit: fewer ER visits.

24. Gene therapy — clarification.
    Purpose: set realistic expectations. Mechanism: honest review of evidence. Benefit: informed choices.
    There is currently no established gene therapy for AVWS; AVWS is acquired, not genetic. Care focuses on hemostasis and treating the underlying cause. PMC

25. Device/underlying-disease counseling.
    Purpose: understand how aortic stenosis, LVAD, or gammopathy causes AVWS. Mechanism: recognize that fixing the cause can fix AVWS. Benefit: long-term control after valve replacement or targeted hematology care. PMC+1

---

Drug treatments

⚠️ Doses below are typical educational ranges; your clinician will individualize based on your condition, kidney function, age, procedures, and local guidelines.

1. Desmopressin (DDAVP) — VWF/FVIII releaser.
   Dose/time: 0.3 mcg/kg IV over 20–30 min (or SC/nasal protocols) before procedures or at bleeding onset; avoid repeating too fast (tachyphylaxis, hyponatremia risk).
   Purpose: boost your own VWF briefly. Mechanism: releases stored VWF from endothelium.
   Side effects: flushing, headache, low sodium (water retention), tachyphylaxis. Ash Publications

2. Plasma-derived VWF/FVIII concentrate (e.g., Humate-P®, Wilate®) — replacement.
   Dose/time: individualized (often 40–80 IU VWF:RCo/kg pre-procedure, then top-ups).
   Purpose: provide functional VWF (±FVIII). Mechanism: directly replaces the missing/cleaved protein.
   Side effects: infusion reactions, thrombosis risk if FVIII gets high. PubMed

3. Recombinant VWF (vonicog alfa; Vonvendi®) — replacement without FVIII.
   Dose/time: individualized per bleed/procedure; FVIII can be co-dosed if needed.
   Purpose: replace VWF while avoiding FVIII accumulation.
   Side effects: infusion reactions, theoretical thrombosis risk. Ash Publications

4. Tranexamic acid — antifibrinolytic.
   Dose/time: 1 g PO/IV every 8 h for mucosal bleeds or peri-dental; mouthwash for dental use as prescribed.
   Purpose: make formed clots last longer. Mechanism: blocks plasminogen activation.
   Side effects: nausea, rare thrombosis; avoid with active DIC/hematuria to kidneys. PubMed

5. Epsilon-aminocaproic acid (EACA) — antifibrinolytic.
   Dose/time: 50–100 mg/kg PO/IV every 6 h (max per local protocol).
   Purpose/Mechanism: same class as tranexamic.
   Side effects: GI upset, rare thrombosis. PubMed

6. Topical hemostatics (thrombin/fibrin sealants; tranexamic mouthwash).
   Use: dental, nasal, minor procedures.
   Purpose: local clot support. Mechanism: concentrates clotting at the site.
   Side effects: minimal; avoid swallowing large amounts of topical agents.

7. Intravenous immunoglobulin (IVIG) — immunomodulator.
   Dose/time: 1 g/kg daily ×1–2 days for selected cases (e.g., gammopathy-mediated accelerated VWF clearance); effect is temporary.
   Purpose: block VWF-binding antibodies or paraprotein effects. Mechanism: Fc-mediated immune modulation.
   Side effects: headache, aseptic meningitis, thrombosis risk in predisposed patients. PMC+1

8. Prednisone (systemic corticosteroid) — immunosuppression.
   Dose/time: common starting range 0.5–1 mg/kg/day, taper by response.
   Purpose: reduce autoimmune VWF destruction. Mechanism: dampens antibody production.
   Side effects: glucose rise, mood, infection risk, bone loss.

9. Rituximab — anti-CD20 monoclonal antibody.
   Dose/time: 375 mg/m² IV weekly ×4 (typical lymphoma schedule).
   Purpose: deplete B-cells producing inhibitors/antibodies. Mechanism: B-cell cytolysis.
   Side effects: infusion reactions, infections (HBV reactivation). PubMed

10. Bortezomib — proteasome inhibitor.
    Use: selected refractory AVWS linked to plasma-cell disorders.
    Mechanism: targets clonal plasma cells lowering pathologic antibodies.
    Side effects: neuropathy, cytopenias. PubMed

11. Lenalidomide — immunomodulatory drug.
    Use: case-level evidence for MGUS-related AVWS when standard care fails.
    Mechanism: reduces VWF clearance by controlling the clone.
    Side effects: thrombosis risk (with steroids), cytopenias; needs specialist use. ScienceDirect

12. Octreotide — somatostatin analog.
    Use: recurrent GI bleeding (e.g., angiodysplasia) sometimes seen with Heyde syndrome.
    Mechanism: splanchnic vasoconstriction reduces mucosal bleeding.
    Side effects: GI cramps, gallstones.

13. Hormonal therapy for heavy menstrual bleeding (combined OCPs or levonorgestrel IUD; medical device for the latter).
    Purpose: lighter periods. Mechanism: endometrial thinning.
    Side effects: vary by method; discuss thrombosis history.

14. Recombinant factor VIIa (rFVIIa) — bypass agent, rescue only.
    Use: life-threatening bleeding unresponsive to other therapy.
    Mechanism: directly activates coagulation on platelets.
    Side effects: thrombosis risk; specialist-guided.

15. Thyroid hormone replacement (levothyroxine) if hypothyroidism-associated AVWS.
    Purpose: correct underlying cause; AVWS often resolves when thyroid function normalizes.
    Side effects: overtreatment causes palpitations, bone loss; dosing by TSH with clinician.

---

Dietary molecular supplements

These do not fix VWF but support blood and tissue health. Always discuss with your clinician, especially if you are on antiplatelet/anticoagulant therapy.

1. Iron (e.g., ferrous sulfate 65 mg elemental iron once–twice daily; vitamin C helps absorption).
   Function: rebuilds red cells after blood loss. Mechanism: hemoglobin synthesis.

2. Folate (0.4–1 mg daily, higher only if prescribed).
   Function: DNA synthesis for red cells. Mechanism: supports erythropoiesis.

3. Vitamin B12 (oral 1,000 mcg daily or injections if deficient).
   Function: red cell maturation. Mechanism: cofactor for DNA synthesis.

4. Vitamin C (100–500 mg daily with iron).
   Function: improves iron absorption; supports collagen. Mechanism: reduces ferric to ferrous iron; collagen cross-linking.

5. Vitamin K (dietary intake through greens; supplements only if clinician advises).
   Function: supports vitamin-K–dependent clotting factors if low. Note: does not treat AVWS directly.

6. Protein-rich foods or whey (if tolerated).
   Function: tissue repair. Mechanism: amino acids for healing.

7. Zinc (up to ~8–11 mg/day from diet/supplement unless otherwise directed).
   Function: mucosal repair and immunity.

8. Copper (only if deficient).
   Function: helps iron mobilization. Mechanism: ceruloplasmin function.

9. Probiotics (food-based like yogurt/kefir).
   Function: gut health in people with frequent GI bleeds/iron therapy. Mechanism: microbiome support.

10. Electrolyte fluids during heavy bleeding days (oral solutions).
    Function: maintain volume and perfusion; helps dizziness. Mechanism: replaces salt and water.

Avoid or limit bleeding-risk herbs/supplements unless your prescriber approves: ginkgo, garlic, ginseng, fish oil, high-dose turmeric, high-dose vitamin E.

---

Regenerative / stem-cell” drugs

There is no proven stem-cell or regenerative drug for AVWS. However, immunomodulatory therapies can help when the immune system or a paraprotein clears VWF too fast:

1. IVIG — short-term immune blocking in paraproteinemia-mediated AVWS; effect is temporary. PMC+1

2. Rituximab — targets B-cells that make anti-VWF antibodies.

3. Bortezomib — reduces clonal plasma cells in MGUS/myeloma-linked AVWS.

4. Lenalidomide — selected refractory MGUS-related AVWS; case-based evidence. ScienceDirect

5. Corticosteroids — broad immune dampening for autoimmune forms.

6. Daratumumab (anti-CD38) — specialist-only option for difficult plasma-cell disorders; may indirectly resolve AVWS by controlling the clone.

These are specialist hematology treatments, chosen only after careful work-up of the underlying disease.

---

Procedures/surgeries

1. Aortic valve replacement (SAVR or TAVR) for Heyde syndrome (aortic stenosis + AVWS ± GI bleeding).
   Why: removes high-shear valve, restores large VWF multimers, and often stops GI bleeding.
   Evidence: meta-analysis shows high rates of AVWS recovery and GI bleed cessation after AVR. PMC

2. LVAD management (pump speed optimization) or heart transplant in select cases.
   Why: reduce shear that destroys VWF. Note: nearly all LVAD patients lose large VWF multimers soon after implantation. JACCAnnals of Thoracic Surgery

3. Therapeutic plasma exchange (plasmapheresis) before urgent procedures in antibody/paraprotein-mediated AVWS.
   Why: temporarily removes the inhibitor or paraprotein to allow VWF therapy to work.

4. Endoscopic treatment of angiodysplasia (argon plasma coagulation/clipping).
   Why: seal bleeding GI lesions common in Heyde syndrome.

5. Tumor or spleen surgery (very selected situations).
   Why: remove a source of VWF adsorption or destruction (e.g., some tumors with high VWF binding); splenectomy is uncommon and reserved for special cases after expert review.

---

Prevention habits

1. Tell every clinician and dentist you have AVWS.

2. Plan before procedures (hematology note, DDAVP/VWF or antifibrinolytic plan).

3. Use soft toothbrush, gentle flossing, and humidify air to prevent nose/mouth bleeds.

4. Review medicines and avoid NSAIDs/aspirin unless your cardiologist requires them; discuss safer pain options.

5. Limit or avoid alcohol binges (irritates mucosa and affects platelets).

6. Exercise smart: low-impact, warm-up, protective gear.

7. Keep iron stores healthy with food and, if needed, supplements guided by labs.

8. Manage blood pressure and allergies (less nose blowing, less epistaxis).

9. Vaccinate and use hand hygiene to reduce infection-triggered bleeds.

10. If you have a known underlying cause (e.g., valve disease, gammopathy, hypothyroidism), keep it treated and follow up regularly. Ash Publications

---

When to see a doctor now

• Bleeding that does not stop with pressure/ice in 10–15 minutes.

• Black stools, vomiting blood, or bright red rectal bleeding.

• Heavy menstrual bleeding soaking ≥1 pad/tampon per hour over several hours.

• New, large, or painless bruises without clear cause.

• Dizziness, fainting, chest pain, or shortness of breath with bleeding.

• Before any surgery, dental extraction, or invasive test.

• If you have an LVAD/ECMO or are told you have aortic stenosis, ask about AVWS screening. Frontiers

---

What to eat and what to avoid

1. Eat iron-rich foods (lean red meat, liver, beans, lentils) plus vitamin C sources (citrus, guava) together.

2. Eat leafy greens (vitamin K) as part of a steady diet (do not make sudden big changes if on anticoagulants).

3. Eat protein with each meal (eggs, dairy, tofu, fish) to support healing.

4. Eat colorful fruits/vegetables for vessel health.

5. Drink enough water; dehydration can worsen dizziness during bleeds.

6. Avoid/limit herbs and supplements that may thin blood (ginkgo, garlic, ginseng, high-dose fish oil, turmeric, vitamin E) unless your clinician approves.

7. Avoid alcohol binges.

8. Avoid very hard/crusty foods if you have frequent gum bleeds; take smaller bites and chew slowly.

9. Avoid NSAIDs for pain unless prescribed; use alternatives recommended by your doctor.

10. Avoid crash diets that cause vitamin or protein deficiencies.

---

FAQs

1. Is AVWS the same as inherited VWD?
   No. It looks similar on lab tests, but AVWS starts later in life and is caused by another condition or device. PMC

2. What problems cause AVWS?
   Often heart valve disease (especially aortic stenosis), LVAD/ECMO, blood cancers or gammopathy, autoimmune disease, hypothyroidism, or some drugs/devices. PMC+1

3. Why does a tight aortic valve cause bleeding?
   High-speed blood flow shreds the biggest VWF multimers, making platelets less sticky. PMC

4. Can fixing the valve fix AVWS?
   Yes, valve replacement (SAVR/TAVR) often restores VWF multimers and stops recurrent GI bleeding. PMC

5. How is AVWS diagnosed?
   History (no family bleeding), bleeding symptoms, and labs showing low VWF activity and loss of high-molecular-weight multimers; specialized ratios (e.g., VWF:RCo or VWF:CB vs antigen) help. Frontiers

6. What is the first medicine used during a bleed?
   Desmopressin or VWF concentrate, plus tranexamic acid for mucosal bleeding, depending on cause and plan. Ash PublicationsPubMed

7. Will IVIG cure AVWS?
   No. It may help temporarily in antibody/paraprotein-mediated AVWS. The effect wears off. PMC+1

8. Do I need treatment every day?
   Usually not. Many people are treated only for bleeds or before procedures, while the underlying problem is addressed. Ash Publications

9. Are antifibrinolytics safe?
   They are widely used but must be avoided in certain situations (e.g., active DIC, gross hematuria). Your clinician will decide. PubMed

10. Can I play sports?
    Yes, choose low-impact options; use protective gear and a warm-up plan.

11. Do I need to stop aspirin or clopidogrel?
    Never stop heart medicines on your own. Discuss risks and alternatives with your cardiologist/hematologist.

12. Can heavy periods be controlled?
    Yes, with tranexamic acid, hormonal therapy, or VWF therapy around procedures; plan with your clinicians.

13. Does diet fix AVWS?
    Diet does not repair VWF, but it supports blood building and recovery.

14. Is gene therapy available for AVWS?
    No established gene therapy for AVWS today. PMC

15. What is the most important step for long-term control?
    Treat the underlying cause (e.g., valve disease, plasma-cell disorder, thyroid disease); this often resolves AVWS. PMC

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 02, 2025.